Equities

Dawnrays Pharmaceutical (Holdings) Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Dawnrays Pharmaceutical (Holdings) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.24
  • Today's Change0.00 / 0.00%
  • Shares traded396.00k
  • 1 Year change+3.33%
  • Beta0.3721
Data delayed at least 15 minutes, as of Jul 04 2025 07:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in the development, manufacture and sale of non-patented pharmaceutical medicines. The products include intermediate pharmaceutical, bulk medicines and finished drugs. The Company operates its business through two segments. The Intermediates and Bulk Medicines segment is engaged in the manufacture and sale of intermediates and bulk medicines. The Finished Drugs segment is engaged in the manufacture and sale of finished drugs, including antibiotics finished drugs and non-antibiotics finished drugs.

  • Revenue in HKD (TTM)1.16bn
  • Net income in HKD618.64m
  • Incorporated2002
  • Employees1.18k
  • Location
    Dawnrays Pharmaceutical (Holdings) LtdUnits 3001-02, 30/F, CNT Tower, Wanchai Hong KongHKG
  • Phone+852 21119708
  • Fax+852 21119870
  • Websitehttps://www.dawnrays.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
3D Medicines Inc488.01m-200.03m1.12bn191.00--1.31--2.30-0.8165-0.81651.993.330.3378.4416.722,555,018.00-15.08---22.10--91.79---44.74--2.02--0.2524---29.81--65.19------
Cryofocus Medtech Shanghai Co Ltd58.62m-114.29m1.19bn276.00--14.72--20.31-0.478-0.4780.24520.33820.29570.5577--212,389.30-61.47---87.48--71.75---207.87--1.14--0.3544--30.72---7.06------
Jilin Provnc Hnn Chnglng Bio-pharm CoLtd964.92m201.76m1.19bn745.005.910.66875.161.240.36010.36011.723.190.36342.403.151,295,190.007.607.4611.2910.4577.7777.8020.9120.451.21--0.042544.004.716.4124.324.95-8.31--
Meilleure Health Intrntnl Indu Grp Ltd50.68m32.48m1.21bn46.0037.151.00--23.830.00790.00790.01240.29360.03010.08310.95621,101,652.001.902.742.153.0257.0447.1863.2428.592.72--0.201541.83-60.81-26.41-20.45---1.03--
Zhaoke Ophthalmology Ltd75.91m-260.07m1.38bn294.00--0.6615--18.13-0.469-0.4690.13753.810.02971.6727.24258,209.80-10.18-38.02-11.83-41.7974.72---342.58-4,412.895.11-24.050.1116--269.73--38.32--18.80--
Dawnrays Pharmaceutical (Holdings) Ltd1.16bn618.64m1.86bn1.18k3.010.51162.611.610.41150.41150.7712.420.27791.867.72981,485.9014.7510.9817.5813.7554.4855.5253.0832.763.42--0.010331.01-7.892.2273.2917.2017.132.69
SinoMab Bioscience Ltd2.22m-202.74m2.46bn95.00--10.54--1,107.61-0.1888-0.18880.00210.19350.0025----23,353.51-23.13-22.26-30.23-25.6826.80---9,138.25-3,832.94---8.520.7143--48.42--23.85---0.376--
Essex Bio-Technology Ltd1.67bn307.22m2.60bn1.45k8.631.237.171.560.53170.53172.873.740.57482.813.071,151,598.0010.5710.2814.3213.6289.7587.7318.4018.701.73--0.080917.49-3.875.4711.610.3101-7.477.14
Jbm (Healthcare) Ltd782.29m197.26m2.66bn279.0013.452.4410.453.400.24090.24090.9551.330.53334.245.792,803,914.0013.826.5717.647.8352.8847.8225.9116.601.32--0.1286--20.6515.4451.2036.90----
Data as of Jul 04 2025. Currency figures normalised to Dawnrays Pharmaceutical (Holdings) Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

10.53%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 May 202597.50m6.49%
UBS Asset Management (Hong Kong) Ltd.as of 31 Mar 202537.04m2.47%
Dimensional Fund Advisors LPas of 05 Jun 202513.43m0.90%
Fidelity Investments Canada ULCas of 31 May 20257.21m0.48%
Strategic Advisers LLCas of 31 May 20251.93m0.13%
Dimensional Fund Advisors Ltd.as of 30 Nov 2024708.09k0.05%
DFA Australia Ltd.as of 31 May 2025223.69k0.02%
Acadian Asset Management LLCas of 31 May 202579.49k0.01%
FIL Investments Internationalas of 31 Dec 202476.43k0.01%
American Century Investment Management, Inc.as of 31 May 20257.00k0.00%
More ▼
Data from 31 Mar 2025 - 30 May 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.